Therapeutic Drug Monitoring Market to Hit USD 3.44 Billion by 2029 with 8.4% CAGR | MarketsandMarkets | PR Newswire [Video]

, /PRNewswire/ — The global therapeutic drug monitoring market would expand at a compound annual growth rate (CAGR) of 8.4% from USD 2.30 billion in 2024 to USD 3.44 billion by 2029. The main cause of this increase is the rising incidence of lifestyle-related and chronic illnesses including cancer and heart disease, which require careful medication control. The market’s growth is also being driven using AI-powered diagnostic solutions and technological advancements like chromatography and immunoassays. Furthermore, the market is being driven by increasing expenditures in healthcare infrastructure, the focus on increasing transplant success rates, and precision medicine regulatory measures.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443

Browse in-depth TOC on “Therapeutic Drug Monitoring Market“

437 – Tables

59 – Figures

380 – Pages

The major technical development is the use of machine learning and AI to TDM. Such AI-powered solutions foster better treatment planning and improved medication concentration predicts through real-time assessment of patient data. Advances in non-invasive sample methods, such saliva-based TDM, …